UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November
2026
Commission File Number: 001-42213
WeRide Inc.
21st Floor, Tower A, Guanzhou Life Science Innovation
Center
No. 51, Luoxuan Road, Guangzhou International
Biotech Island
Guangzhou 510005
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXPLANATORY NOTE
WeRide
Inc. made an announcement dated November 6, 2026 with the Stock Exchange of Hong Kong Limited in relation to the date of board
meeting. For details, please refer to the exhibit to this current report on Form 6-K.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Announcement – Date of Board Meeting |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
WeRide Inc. |
| |
|
|
| |
By: |
/s/ Jennifer Li |
| |
Name: |
Jennifer Li |
| |
Title: |
Chief Financial Officer |
Date: November 6, 2026
Exhibit 99.1
Hong Kong Exchanges and Clearing Limited
and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to
its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the
whole or any part of the contents of this announcement.

WeRide
Inc.
文遠知行*
(A company controlled
through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock
Code: 0800)
DATE
OF BOARD MEETING
The board of directors (the “Board”)
of WeRide Inc. (the “Company,” together with its subsidiaries, the “Group”) hereby announces that
a meeting of the Board will be held on Friday, November 20, 2026 Beijing/Hong Kong Time, for the purposes of, among other things, considering
and approving the unaudited quarterly results of the Group for the three months ended September 30, 2026 and its publication.
The Company’s management team will
hold an earnings conference call at 9:00 P.M. Beijing/ Hong Kong Time on Friday, November 20, 2026 or at 8:00 A.M. U.S. Eastern Time on
Friday, November 20, 2026 to discuss the results. Details for the conference call are as follows:
Event Title: WeRide Inc. Third
Quarter 2026 Earnings Call
English Registration Link: https://register-conf.media-server.com/register/BIfea88546dc6b410cb55a66c8e874bc2e
Chinese Simultaneous Interpretation
Registration Link (listen-only mode): https://register-conf.media-server.com/register/BI0566d324693c403dbc3fce728df2fc80
All participants are required to complete
the online registration in advance using the links provided above. During the registration, participants may select either the English
or Chinese simultaneous interpretation options. Please note that the Chinese simultaneous interpretation line will be available in listen-only
mode. Upon successful registration, each participant will receive a confirmation email containing the relevant dial-in details and a unique
access PIN, which can be used to join the conference call.
Additionally, a live and archived webcast
of the conference call will be available on the Company’s investor relations website at https://ir.weride.ai.
| |
By Order of the Board |
| |
WeRide Inc. |
| |
Dr. Tony Xu Han |
| |
Chairman of the Board, Executive Director |
| |
and Chief Executive Officer |
Hong Kong, November 6, 2026
As at the date of this announcement,
the Board comprises Dr. Tony Xu Han and Dr. Yan Li as executive Directors, Mr. Ichijo Futakawa and Mr. Jean-François Salles as
non-executive Directors, and Ms. Huiping Yan, Mr. David Zhang and Dr. Tony Fan-cheong Chan as independent non-executive Directors.
* For
identification purposes only